ST. LOUIS--(BUSINESS WIRE)--GenoMed (Pink Sheets:GMED), a Next Generation Disease Management company that uses genomics to solve diseases in humans and animals, today announced that the fourth horse in its expanded trial for West Nile virus encephalitis is recovering nicely one week after starting GenoMed’s treatment.
